Lithium Carbonate Tablet, Extended Release
Product Images NDC 46708-148

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 46708-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Lithium 300mg)

Each tablet contains Lithium Carbonate USP 200mg. This medication comes in extended-release tablets and is used as a mood stabilizer to treat bipolar disorder. The usual dosage instructions can be found in the accompanying insert. This medication should be stored in a tightly sealed and child-resistant container at a controlled room temperature of 20°C to 25°C (68°F to 77°F). This medication is manufactured by Aembic Pharmaceuticals Limited, a formulation division, located in Gujarat, India. It is important to protect the medication from moisture and flames. The NDC number for this medication is 46708-148-30 and it is available in 30 tablet size. The label also displays a batch and an expiration date. This medication requires a prescription from a doctor or other licensed healthcare provider.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.